Vaccine Safety & Efficacy

Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.

 


 


    Related Conference of Vaccine Safety & Efficacy

    August 16-16, 2021

    3rd World Conference on Vaccine and Immunology

    Dubai, UAE
    August 27-28, 2021

    5th International Conference on Emerging Infectious Diseases

    Amsterdam, Netherlands
    September 20-21, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    October 12-13, 2021

    International Conference on Vaccine and Vaccine research

    Manila, Philippines
    October 14-15, 2021

    13th Annual Conference on Clinical Immunology

    Cape Town, South Africa
    November 04-05, 2021

    9th World Summit on Immunology & Immunotherapy

    Prague, Czech Republic
    November 08-09, 2021

    International Conference on Immunology Research

    Las Vegas, USA
    February 07-08, 2022

    International Conference on Vaccine Research

    Paris, France
    March 21-22, 2022

    36th International Conference on Immunology

    Rome, Italy
    March 21-22, 2022

    15th Global Summit on Immunology and Cell Biology

    Tokyo, Japan

    Vaccine Safety & Efficacy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in